Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians

BACKGROUND: Despite advances in cystic fibrosis (CF) management and survival, the optimal treatment of pulmonary exacerbations remains unclear. Understanding the variability in treatment approaches among physicians might help prioritise clinical uncertainties to address through clinical trials. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Grace, Tai, Anna, Snelling, Tom, Schultz, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286763/
https://www.ncbi.nlm.nih.gov/pubmed/34266854
http://dx.doi.org/10.1136/bmjresp-2021-000956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286763/
https://www.ncbi.nlm.nih.gov/pubmed/34266854
http://dx.doi.org/10.1136/bmjresp-2021-000956

Ejemplares similares